Patent · US Active

Compounds and methods of treating retinal degeneration

US12251373B2 · kind B2 · utility

0Cited by
4References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 5, 2023
Grant dateMar 18, 2025
Priority date
Expiry dateSep 5, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating retinal degeneration in a subject includes administering to the subject a therapeutically effective amount of a compound of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.